(Q39226360)

English

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.

scientific article published on 21 March 2014

Statements

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors. (English)
0 references
Jordi Rodon
Irene Braña
Lillian L Siu
Maja J De Jonge
Natasha Homji
David Mills
Emmanuelle Di Tomaso
Celine Sarr
Lucia Trandafir
Cristian Massacesi
Ferry Eskens
Johanna C Bendell
21 March 2014
670-681

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit